~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Astaxanthin compound found to switch on the FOX03 'Longevity Gene' in mice - Science Daily, 3/28/17 - "The Astaxanthin compound CDX-085 (developed by Cardax) showed the ability to significantly increase the expression of the FOXO3 gene, which plays a proven role in longevity ... We found a nearly 90% increase in the activation of the FOXO3 "Longevity Gene" in the mice fed the higher dose of the Astaxanthin compound CDX-085" - See BioAstin at Amazon.com .  Other recent studies on astaxanthin:

• Preventive effect of dietary astaxanthin on UVA-induced skin photoaging in hairless mice - PLoS One. 2017 Feb 7;12(2):e0171178 - "Our results indicate that dietary astaxanthin accumulates in the skin and appears to prevent the effects of UVA irradiation on filaggrin metabolism and desquamation in the epidermis and the extracellular matrix in the dermis" - [Nutra USA]
• Clinical Study Shows AstaReal(R) Astaxanthin Effective in Reducing both Mental and Physical Fatigue - yonhapnews.co.kr, 11/7/16 - "AstaReal® astaxanthin significantly reduced perceived symptoms of mental and physical fatigue compared to the placebo. These included improvements in clarity of thinking, concentration, motivation, and mood. Irritation and feeling of body heaviness were reduced. In the calculation test, an increase in errors observed in the placebo during the second half of the test was almost eliminated in the astaxanthin group. Supplementation with astaxanthin also significantly reduced salivary cortisol, a biomarker for stress" - [Nutra USA] - See astaxanthin at Amazon.com.

Larger doses of vitamin C may lead to a greater reduction in common cold duration - Science Daily, 3/30/17 - "The dose-response relationship in these two trials was also quite linear up to the levels of 6-8 g/day, thus it is possible that even higher doses may lead to still greater reductions in the duration of common cold" - See American Health Products - Ester C W/Citrus Bioflavonoids, 1000 mg, 180 veg tablets at Amazon.com.

High doses of vitamin C to improve cancer treatment passes human safety trial - Science Daily, 3/30/17 - "Clinical trials found that it is safe to regularly infuse brain and lung cancer patients with 800 -- 1000 times the daily recommended amount of vitamin C as a potential strategy to improve outcomes of standard cancer treatments ... This guarded optimism is based on the phase I trial data showing an increase in overall survival of 4-6 months in 11 glioblastoma multiforme patients (18-22 months) versus the 14-16 months survival typically seen with the standard treatment"